Ultrasound Guidance for Embryo Transfer
Transvaginal Versus Transabdominal Ultrasound Guided Embryo Transfer. Randomized Controlled Trial.
1 other identifier
interventional
178
1 country
2
Brief Summary
Randomized controlled study comparing the TVUS versus TAUS guidance during the procedure of embryo transfer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 2, 2016
CompletedFirst Submitted
Initial submission to the registry
February 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2019
CompletedFirst Posted
Study publicly available on registry
February 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2019
CompletedMarch 12, 2019
March 1, 2019
2.7 years
February 5, 2019
March 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy
A clinical pregnancy is a pregnancy that is confirmed by ultrasonic visualization of gestational sac or heartbeat.
3 weeks after Embryo transfer
Secondary Outcomes (3)
Time required for ET
Time from when the catheter is handed to the transferring physician to the time it is returned to the transferring embryologist.
Degree of cramping and pain
During and immediately after ET
Endometrial visualization at time of embryo transfer
During ET
Study Arms (2)
Transvaginal Ultrasound Guided ET
EXPERIMENTALTransvaginal ultrasound is used to guide ET
Transabdominal Ultrasound Guided ET
EXPERIMENTALTransabdominal ultrasound is used to guide ET
Interventions
Use of TVUS to guide ET
Use of TAUS to guide ET
Eligibility Criteria
You may qualify if:
- All patients undergoing autologous ICSI and frozen embryo transfer (FET) cycles.
You may not qualify if:
- Cases of sever ovarian hyperstimulation requiring embryo cryopreservation
- Gestational surrogate cycles
- Oocyte donation cycles
- Very poor responders
- Patients with inadequate visualization of the uterus by ultrasound.
- Very difficult mock embryo transfer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Menoufia Universitylead
- Alexandria Universitycollaborator
Study Sites (2)
Menoufia University
Shibīn al Kawm, Monofiya, 32511, Egypt
Alexandria University
Alexandria, 94109, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamad S kandil, MD
Menoufia University
- STUDY DIRECTOR
Sherif S Gaafar, MD
Alexandria University
- PRINCIPAL INVESTIGATOR
Haitham A Hamza, MD
Menoufia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Obstetrics and Gynecology
Study Record Dates
First Submitted
February 5, 2019
First Posted
February 22, 2019
Study Start
June 2, 2016
Primary Completion
February 15, 2019
Study Completion
March 9, 2019
Last Updated
March 12, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share